Dr Sekhar Basu, Chairman, AEC emphasized the need of supporting Indian industries towards manufacturing of deuterated compounds to fulfill the mission of 'Make in India' campaign. The advantage of Indian expertise in this field will reach masses through end products developed by Indian Pharmaceutical and other Industries. This is expected to lead towards lots of R&D in the field of development of new deuterated compounds and Active Pharma Ingredients. Dr Basu also advised that the technology development in this field can be taken up by the Indian companies through Technology Transfer & Collaboration Division of BARC by entering into collaborative arrangements on various science and technology products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content